• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 11/18/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Finance

  • 2:40 PM

    IEGH Provided $1,130,000 in New Consumer Loans in May LAS VEGAS, NV– IEGH, (Marketwired – June 01, 2016) – IEG Holdings Corporation (OTCQX: IEGH) announced today that daily loan volume hit a record high of $150,000 and monthly loan volume hit a record high of $1,130,000 in May. Since January 2015, cumulative loan volume has increased by 133% from $5,549,023 to $12,909,023 as of May 31, 2016. Paul Mathieson, CEO of IEG Holdings, said, “Management has shown an ability to

    Read more
  • 2:33 PM

    Funds raised will support ongoing Phase II(b) clinical trial in Basal Cell Carcinoma Nevus Syndrome, an orphan cancer hereditary disease requiring life-long therapy with no approved pharmaceutical treatment License and Manufacturing Partner Mayne Pharma invests $2.8MM PR Newswire TAMPA, Fla. and SAN DIEGO, June 1, 2016 TAMPA, Fla. and SAN DIEGO, June 1, 2016 /PRNewswire/ — HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced

    Read more
  • 2:56 PM

    CONVERSE, Ind., May 31, 2016, FFMR, /PRNewswire/ — First Farmers Financial Corp. (OTCQX Banks: FFMR), the parent company of First Farmers Bank & Trust Co., was listed 7th nationally among community banks in American Banker magazine’s annual Top 200 rankings based on return on equity average over the course of the last three years (15.33% ROAE). It is the 3rd straight year that First Farmers has placed in the top 5% nationally among peers of less than $2 billion in

    Read more
  • 3:18 PM

    FRAMINGHAM, MA– ARTH, (Marketwired – May 27, 2016) – Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of the AC5 Surgical Hemostatic Device™ (AC5™) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to announce that it has entered into subscription agreements with a group of accredited investors (the “Investors”) to purchase approximately $3.4 million of the Company’s securities in a private placement pursuant to Section

    Read more
  • 2:53 PM

    MOUNTAIN VIEW, Calif., May 24, 2016, SNPS, /PRNewswire/ — Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase Bank, National Association, to repurchase $125 millionof Synopsys stock. Under the terms of the ASR, Synopsys will receive an initial share delivery of approximately 2.0 million shares, with the remainder to be settled on or before August 15, 2016, upon completion of the repurchase. The specific number of shares that Synopsys

    Read more
  • 2:17 PM

    May 24, 2016 OTC Disclosure & News Service, PURE – PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company raised $1.27 million from the recent exercise by all of the holders of the 2,820,670 warrants expiring May 23, 2016. Use of proceeds will include the commercialization of FDA approved PURE Control® antimicrobial as a processing aid for fresh produce and for raw poultry. PURE Control is a superior, broad spectrum,

    Read more
Public Wire Banner